Thu, 29 Sep 2022

NEW YORK, NY / ACCESSWIRE / August 5, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

VRCA Shareholders Click Here: https://www.zlk.com/pslra-1/verrica-pharmaceuticals-inc-loss-submission-form?prid=30619&wire=1
MF Shareholders Click Here: https://www.zlk.com/pslra-1/missfresh-limited-loss-submission-form?prid=30619&wire=1
ENOB Shareholders Click Here: https://www.zlk.com/pslra-1/enochian-biosciences-loss-submission-form?prid=30619&wire=1

* ADDITIONAL INFORMATION BELOW *

Levi & Korsinsky, LLP, Friday, August 5, 2022, Press release picture

Verrica Pharmaceuticals, Inc. (NASDAQ:VRCA)

VRCA Lawsuit on behalf of: investors who purchased May 28, 2021 - May 24, 2022
Lead Plaintiff Deadline : August 5, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/verrica-pharmaceuticals-inc-loss-submission-form?prid=30619&wire=1

According to the filed complaint, during the class period, Verrica Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced a bulk solution for the Company's lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Missfresh Limited (NASDAQ:MF)

This lawsuit is on behalf of persons who purchased or otherwise acquired Missfresh securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Missfresh's June 2021 initial public offering.
Lead Plaintiff Deadline : September 12, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/missfresh-limited-loss-submission-form?prid=30619&wire=1

According to the filed complaint, (1) Missfresh provided false financial figures in its registration statement
and related prospectus issued in connection with the Company's June 2021 initial public offering; (2) Missfresh would need to amend its financial figures; (3) Missfresh, among other things, had lesser net revenues for the quarter ended March 31, 2021; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared.

Enochian BioSciences, Inc. (NASDAQ:ENOB)

ENOB Lawsuit on behalf of: investors who purchased January 17, 2018 - June 27, 2022
Lead Plaintiff Deadline : September 26, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/enochian-biosciences-loss-submission-form?prid=30619&wire=1

According to the filed complaint, during the class period, Enochian BioSciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu's purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE : Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/710993/CLASS-ACTION-UPDATE-for-VRCA-MF-and-ENOB-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

More Orlando News

Access More

Sign up for The Orlando News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!